Is Opt Health legit and worth it?
Opt Health is a real GLP-1 telehealth provider; we read its site and scored it 4.0/5 in our independent review (Strong Choice). Biggest plus: Lab testing included. Watch-out: No/minimal Trustpilot reviews.
Scorecard: strongest in Clinical Quality (4.8/5) and Patient Protection (4.8/5); weakest in Authenticity (2.9/5) and Reputation (3.1/5).
Medications
Semaglutide (as listed on its site, 7 April 2026)
Monthly Cost
$199-$399 (as listed on its site, 7 April 2026)
Speed to Start
Moderate
Trustpilot
Not yet rated (as recorded April 2026; not re-checked)
Prices and medications in this review are as listed on Opt Health’s site on 7 April 2026, unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2019
About Opt Health
Opt Health launched in 2019 as a men’s health optimization platform, positioning itself as a concierge-level telehealth service for men seeking to improve energy, body composition, and overall metabolic health. The company offers compounded semaglutide as part of its weight management program, with monthly costs ranging from $199 to $399. Opt Health’s approach emphasizes personalized treatment plans built on comprehensive diagnostics, setting it apart from providers that take a more transactional approach to GLP-1 prescribing.
Trust data for Opt Health is limited. The company has no Trustpilot reviews on its Trustpilot page at the time of this review, which means we cannot assess public patient sentiment through that channel. The absence of a robust public review profile is a gap that prospective patients should factor into their decision, particularly given that more established telehealth providers in this space typically offer thousands of verified reviews to draw on.
Where Opt Health excels is in its high-support clinical model. The platform includes lab testing as a standard part of its program, and treatment plans are built around individual metabolic profiles rather than standardized protocols. Patients work with dedicated providers who monitor progress, adjust dosing, and coordinate care across multiple health domains. For men managing weight alongside testosterone optimization, thyroid health, or cardiovascular risk factors, this integrated approach can produce better outcomes than siloed treatment.
The personalized treatment philosophy extends to Opt Health’s patient experience. The platform markets itself as a premium service, and patients report receiving more one-on-one provider time than typical telehealth encounters offer. This concierge-style model justifies the mid-to-upper pricing tier for patients who value relationship-based care over cost minimization. However, the premium positioning also means Opt Health is not competitive on price alone — patients primarily motivated by affordability will find better options elsewhere.
The limitation of offering only compounded semaglutide narrows Opt Health’s appeal. Patients interested in tirzepatide, liraglutide, or brand-name GLP-1 formulations will need to look elsewhere. Combined with the lack of public reviews, Opt Health is a provider we respect for its clinical philosophy but cannot fully validate through independent patient data. It earns points for care quality and loses them for transparency and medication breadth.
Opt Health GLP-1 Medications
Screenshot of Opt Health, captured by 10 April 2026
Screenshot of Opt Health, captured by 10 April 2026
Screenshot of Opt Health, captured by 10 April 2026
Screenshot of Opt Health, captured by 10 April 2026
Screenshot of Opt Health, captured by 10 April 2026
How GLP-1 Access Works at Opt Health
Opt Health does not offer a stand-alone GLP-1 intake. The public signup at app.getopt.com/signup collects basic demographics (name, email, state, gender) and routes prospective patients into a $195 Optimization Panel — a 55+ biomarker lab test covering insulin resistance, inflammation, thyroid, hormones, and cardiovascular markers. Only after that lab work is processed does a physician build a “personalized care plan,” and compounded semaglutide is one possible outcome rather than a directly selectable product. The cash-pay structure starts at the $195 panel fee plus the medication subscription if prescribed; insurance is not accepted. If a faster, GLP-1-first signup is what you need, Opt Health’s biomarker-first model may not be the right fit.
At a Glance
Medications Offered
Semaglutide (as listed on its site, 7 April 2026)
Compounded
Cost & Insurance
- Monthly: $199-$399 (as listed on its site, 7 April 2026)
- 6-month estimate: $1,194-$2,394 (as listed on its site, 7 April 2026)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: No
- Pharmacies named: Not disclosed
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
Start with Opt Health’s $195 Optimization Panel — GLP-1 may be prescribed after lab work and physician review
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
